Juvenile idiopathic arthritis
|Juvenile idiopathic arthritis|
Juvenile idiopathic arthritis (JIA), also known as juvenile rheumatoid arthritis, is the most common form of arthritis in children and adolescents. ("Juvenile" in this context refers to an onset before age 16, "idiopathic" refers to a condition with no defined cause, and "arthritis" is the inflammation of the synovium of a joint.)
JIA is an autoimmune, noninfective, inflammatory joint disease of more than 6 weeks duration in children less than 16 years of age. The disease commonly occurs in children from the ages of 1 to 6, but it may develop as late as 15 years of age. It is a subset of arthritis seen in childhood, which may be transient and self-limited or chronic. It differs significantly from arthritis commonly seen in adults (osteoarthritis, rheumatoid arthritis), and other types of arthritis that can present in childhood which are chronic conditions (e.g. psoriatic arthritis and ankylosing spondylitis). Aetiopathology is similar to rheumatoid arthritis, but with less marked cartilage erosion, and joint instability and absent rheumatoid factor.
JIA affects about one in 1,000 children in any given year, with about one in 10,000 having a more severe form.
- 1 Signs and symptoms
- 2 Causes
- 3 Diagnosis
- 4 Treatment
- 5 Prognosis
- 6 Epidemiology
- 7 Terminology
- 8 Famous patients
- 9 References
- 10 External links
Signs and symptoms
Symptoms of JIA are often nonspecific initially, and include lethargy, reduced physical activity, and poor appetite. in The first manifestation, particularly in young children, may be limping. Children may also become quite ill, presenting with flu-like symptoms that persist. The cardinal clinical feature is persistent swelling of the affected joint(s), which commonly include the knee, ankle, wrist, and small joints of the hands and feet. Swelling may be difficult to detect clinically, especially for joints such as those of the spine, sacroiliac joints, shoulder, hip, and jaw, where imaging techniques such as ultrasound or MRI are very useful.
Pain is an important symptom. Morning stiffness that improves later in the day is a common feature (this implies inflammatory-type joint pain versus mechanical-type joint pain). Late effects of arthritis include joint contracture (stiff, bent joint due to fibrosis) and joint damage. Children with JIA vary in the degree to which they are affected by particular symptoms. Symptoms may also differ between sexes, affecting girls and boys differently among different geographic locations. This is predicted to be due to biological differences in different geographic regions. Children may also have swollen joints (inflammatory swelling, or in chronic arthritis due to synovial membrane proliferation and thickening, and periarticular soft-tissue swelling).
Eye disease: JIA is associated with inflammation in the front of the eye (specifically iridocyclitis, a form of chronic anterior uveitis), which affects about one child in five who has JIA, most commonly girls. This complication is usually asymptomatic and can be detected by an experienced optometrist or ophthalmologist using a slit lamp. Later slit lamp features include synechiae. Most children with JIA are enrolled in a regular slit lamp screening program, as poorly controlled chronic anterior uveitis may result in permanent eye damage, including blindness.
Growth disturbance: Children with JIA may have reduced overall rate of growth, especially if the disease involves many joints or other body systems. Paradoxically, individually affected large joints (such as the knee) may grow faster, due to inflammation-induced increased blood supply to the bone growth plates situated near the joints. This can result in leg length discrepancy, and also deformities such as genu valgum. Asymmetrical growth can also affect other bones e.g. discrepancy in digit length. Marked differences in bone age (skeletal maturation) may be seen.
JIA is a chronic disorder, which if neglected, can lead to serious complications. Proper follow-up with health professionals can significantly reduce the chance of developing complications.
A form of eye inflammation called uveitis is common with some types of JIA. The inflamed eyes, if left untreated, can result in glaucoma, scars, cataracts, and even blindness. Often, the eye inflammation occurs without symptoms, or while the JIA is otherwise in remission, thus it is important for all children to get regular eye checkups from an eye physician. The presence of ANA is a predictor of eye involvement (common in oligoarthritis-type JIA).
Growth retardation is common in children with JIA. Moreover, the medications (corticosteroids) used to treat JIA have potent side effects that can limit growth. Other muskuloskeletal issues may include joint contractures, muscle weakness or muscle loss, and osteoporosis.
Children who delay treatment or do not participate in physical therapy, or children with severe disease, can often develop joint deformities of the hand and fingers. Over time, hand function is lost and almost impossible to recover.
The cause of JIA remains unknown. However, the disorder is autoimmune — meaning that the body's own immune system starts to attack and destroy cells and tissues (particularly in the joints) for no apparent reason. The immune system is thought to be provoked by changes in the environment, in combination with mutations in many associated genes and/or other causes of differential expression of genes. Experimental studies have shown that certain mutated viruses may be able to trigger JIA. The disease appears to be more common in girls, and the disease is most common in Caucasians.
Associated factors that may worsen or have been linked to rheumatoid arthritis include:
- Genetic predisposition; When one family member has been diagnosed with rheumatoid arthritis or another autoimmune disorder, the chances are higher that other family members or siblings may also develop arthritis.
- Females are more likely to develop rheumatoid arthritis than males at all ages.
- A strong belief is held that psychological stress may worsen the symptoms of rheumatoid arthritis. However, when the emotional stress is under control, the arthritis symptoms do not always disappear, suggesting that the association is not straightforward.
- Though no distinct immune factor has been isolated as a cause of arthritis, some experts believe that the triggering factor may be something like a virus which then disappears from the body after permanent damage is done.
- Because rheumatoid arthritis is more common in women, perhaps sex hormones may play a role in causing or modulating arthritis. Unfortunately, neither sex hormone deficiency nor replacement has been shown to improve or worsen arthritis.
The cause of JIA, as the word "idiopathic" suggests, is unknown and an area of active research. Current understanding of JIA suggests that it arises in a genetically susceptible individual due to environmental factors.
Diagnosis of JIA is difficult because joint pain in children can be from many other causes. No single test can confirm the diagnosis, and most physicians use a combination of blood tests, X-rays, and clinical presentation to make an initial diagnosis of JIA. The blood tests measure antibodies and the rheumatoid factor. Unfortunately, the rheumatoid factor is not present in all children with JIA. Moreover, in some cases, the blood work is somewhat normal. X-rays are obtained to ensure that the joint pain is not from a fracture, cancer, infection, or congenital abnormality.
In most cases, fluid from the joint is aspirated and analyzed. This test often helps in making a diagnosis of JIA by ruling out other causes of joint pain.
One possible differential diagnosis for JIA is Farber disease, which is a rare, fatal, genetic lysosomal disorder caused by a deficiency of the enzyme acid ceramidase. It has symptoms similar to JIA including swelling, stiffness, and pain at the joints. These joint abnormalities are progressive and develop during early infancy in a patient with Farber disease. Patients with Farber disease typically have subcutaneous nodules and a hoarse or weak voice due to growth of nodules on the larynx. A Farber disease diagnosis can be confirmed by gene sequencing.
There are several other disorders and diseases that present with symptoms similar to JIA. One possibility could be acute pediatric lymphoblastic leukemia in which children will exhibit joint pain and arthritis due to expansion in the lymphoblasts in bone metaphyses. Thrombocytopenia and lymphocytosis are rare in children and should be looked at when identifying the cause of joint pain because both are seen in children with leukemia. Behcet Syndrome is a multisystem disease also with symptoms similar to JIA. The etiology is unknown and it leads to multisystem inflammation. It can progress to aphthous ulcers, genital ulcerations as well as blindness form uvitis. The additional symptoms and age onset, as Behcet syndrome is rarely diagnosed before school age, can help differentiate. Lyme disease can also commonly be confused with JIA due to the arthritis that develops if left untreated or undiagnosed. The systemic arthritis that develops affects multiple joints and can mimic the arthritis caused by JIA. To rule out Lyme Disease an ELISA blood test can be done to identify antibodies towards the bacteria leading to lyme disease.
|Oligoarticular/Pauciarticular JIA (60%)||Systemic JIA/Still's disease (15%)||Polyarticular JIA/Juvenile RA (10%)||Seronegative spondylarthritis Juvenile AS (5%)|
Oligoarticular is used with JIA terminology, and pauciarticular is used with JRA terminology.
This form accounts for about 50% of JIA cases, and usually involves the large joints such as the knees, ankles, and elbows, but smaller joints (such as the fingers and toes) may also be affected. The hip is not affected unlike polyarticular JIA. It is usually not symmetrical, meaning the affected joints are on one side of the body rather than on both sides simultaneously. Length discrepancy and muscle atrophy often happen, which leads to asymmetric growth and risk of flexion contracture. Early childhood onset patients are at risk for developing a chronic iridocyclitis or anterior uveitis, which is inflammation of the eye. This condition often goes unnoticed; therefore, these children should be closely monitored by an ophthalmologist. If ANA+, patient need routine eye exam every 3 months. If ANA- and older than 7 years, they can have eye exam every 6 months. Children with late-onset oligoarticular JIA are at risk for sacroiliitis and spondyloarthropathy; late-onset oligoarticular JIA affects boys more often than girls and is associated with HLA-B27.
Polyarticular JIA affects five or more joints in the first 6 months of disease. This subtype can include the neck and jaw, as well as the small joints usually affected. This type of JIA is more common in girls than in boys. It accounts for about 40% of JIA cases.
Usually, the smaller joints are affected in polyarticular JIA, such as the fingers and hands, although weight-bearing joints such as the knees, hips, and ankles may also be affected. The joints affected are usually symmetrical, meaning that it affects both joints on both sides of the body (such as both wrists.) Children with polyarticular JIA are also at risk for developing chronic iridocyclitis or uveitis and should also be monitored by an optometrist or ophthalmologist. Rheumatoid factor may be positive, i.e. seropositive, in children with polyarticular JIA occurring between 9 and 16 years of age and is associated with HLA DR4 and HLA DW4. This group has poorer prognosis with about 50% progressing to severe disabiling arthritis, persisting into adulthood. It is generally seronegative in JIA occurring below 10 years of age with a milder disease process and responds better to treatment. Seropositivity is rare in children with systemic JIA. Due to the greater number of joints affected by polyarticular JIA, as well as the tendency to worsen over time, polyarticular JIA must be treated aggressively.
Systemic JIA is characterized by arthritis, fever, which typically is higher than the low-grade fever associated with polyarticular, and a salmon pink rash. It accounts for 10-20% of JIA and affects males and females equally, unlike the other two subtypes of JIA, and affects adolescents . It generally involves both large and small joints. Systemic JIA can be challenging to diagnose because the fever and rash come and go. Fever can occur at the same time every day or twice a day (often in late afternoon or evening) with a spontaneous rapid return to baseline (vs. septic arthritis of continuous fever). The rash is discrete, salmon-pink macules of different sizes. It migrates to different locations on skin, rarely persisting in one location more than one hour. The rash is commonly seen on trunk and proximal extremities or over pressure areas.
Systemic JIA may have internal organ involvement - hepatosplenomegaly, lymphadenopathy, serositis, hepatitis, tenosynovitis, etc.
It is also known as "systemic onset juvenile rheumatoid arthritis".
Rheumatoid factor and ANA are generally negative in systemic JIA.
Some doctors include two other, less common forms: enthesitis-related arthritis and psoriatic JIA. Enthesitis is an inflammation of the insertion points of the tendons. This form occurs most often in boys older than 8, large joints of lower extremities are commonly affected; characteristically, it causes back pain, and is linked to ankylosing spondylitis and inflammatory bowel disease. Psoriatic JIA occurs most often in girls, in conjunction with psoriasis or any two of these features - i.e. dactylitit and nail pitting, although joint problems may precede the skin manifestations by several years.
JIA is best treated by a multidisciplinary team. The major emphasis of treatment for JIA is to help the child regain normal level of physical and social activities. This is accomplished with the use of physical therapy, pain management strategies, and social support. Another emphasis of treatment is to control inflammation and extra-articular symptoms quickly. Doing so should help to reduce joint damage and other symptoms, which will help reduce levels of permanent damage leading to disability.
Beneficial advances in drug treatment have been made over the last 20 years. Most children are treated with nonsteroidal anti-inflammatory drugs and intra-articular corticosteroid injections. Methotrexate, a disease-modifying antirheumatic drug (DMARD) is a powerful drug which helps suppress joint inflammation in the majority of JIA patients with polyarthritis (though less useful in systemic arthritis). Newer drugs have been developed recently, such as TNF alpha blockers, such as etanercept. No controlled evidence supports the use of alternative remedies such as specific dietary exclusions, homeopathic treatment, or acupuncture. However, an increased consumption of omega-3 fatty acids proved to be beneficial in two small studies.
Other aspects of managing JIA include physical and occupational therapy. Therapists can recommend the best exercise and also make protective equipment. Moreover, the child may require the use of special supports, ambulatory devices, or splints to help them ambulate and function normally.
Surgery is only used to treat the most severe cases of JIA. In all cases, surgery is used to remove scars and improve joint function.
Home remedies that may help JIA includes getting regular exercises to increase muscle strength and joint flexibility. Swimming is perhaps the best activity for all children with JIA. Stiffness and swelling can also be reduced with application of cold packs, but a warm bath or shower can also improve joint mobility.
In the future, genetic testing may be available allowing earlier detection of JIA. Early detection will help determine the severity of the disease in each child and help identify which therapies will be the most effective and beneficial treatment options.
A common approach to treating a child with JIA typically involves a team of medical professionals including a rheumatologist, occupational therapist (OT), physical therapist (PT), nurse and social worker.
The role of the OT/PT is to help children participate as fully and independently as possible in their daily activities or "occupations", by preventing psychological and physical dependency. The aim is to maximize quality of life, and minimize disruption to the child’s and family’s life. OTs work with children, their families and schools, to come up with an individualized plan which is based on the child’s condition, limitations, strengths and goals. This is accomplished by ongoing assessments of a child’s abilities and social functioning. The plan may include the use of a variety of assistive devices, such as splints, that help a person perform tasks. The plan may also involve changes to the home, encouraging use of uninvolved joints, as well as providing the child and their family with support and education about the disease and strategies for managing it. OT interventions will be changed depending on the progression and remission of JIA, in order to promote age-appropriate self-sufficiency. Early OT involvement is essential. Interventions taught by an OT can help a child adapt and adjust to the challenges of JIA throughout the rest of their life.
OT/PT can provide many strategies to assist children in their dressing routine. Clothes with easy openings and Velcro, as well as devices, such as buttonhooks and zipper pulls can be used. For children who have difficulty bending, a long handled reacher and sock aid is recommended. OTs may also show children how to sit during dressing so less strain is put on their joints.
OT/PT can help children maintain cleanliness through recommending assistive devices. For children who have trouble reaching all areas of their body, a long handled sponge with a soft grip can be provided. If children find it difficult to sit in a bath or stand in a shower, an OT can prescribe a bath bench or bath seat to be installed to help the child remain in a pain free position. If tooth brushing is challenging, a toothbrush with a larger, soft grip or an electric toothbrush may be recommended. For flossing, a flosser with an adapted handle may be provided. Long handled hairbrushes may be used by children who have difficulty reaching the back of their head. Razors handles can be adapted for easier grip, or an electric razor may be used for shaving. The OT can also show girls wishing to use make-up, ways of increasing the sizes of the handles of make-up application tools for easier grip.
For children with pain in their hands and wrists, utensils and devices that are lightweight with large handles as well as other devices (such as angled knives, strap-on utensils, jar and bottle openers, turning handles, door knob extensions, etc.) can be provided to make the task easier, less painful and more enjoyable. Tilted glasses can be used for children who have neck stiffness. Education can be provided about good eating habits that help control bone loss caused by inactivity and drug side effects. Occupational therapists provide a myriad of strategies to assist children with JIA in performing self-care tasks.
One of the best ways occupational or physical therapists (OTs or PTs) can help children with JIA participate in activities with their friends is by helping them make their home exercise programs into play. Exercises are prescribed by both PTs and OTs to increase the range a child can move a joint and strengthen the joint to decrease pain and stiffness and prevent further limitations in their joint movements. OTs can provide children with age-appropriate games and activities to allow the children to practice their exercises while playing and socializing with friends. Examples are crafts, swimming, and noncompetitive sports.
OTs often prescribe custom-made orthotics to support and correct body position and function. Orthotics maintain alignment reduce discomfort in the legs and back when children participate in physical activities such as sports. Splints can be used to support the joints during activity, to reduce the children’s pain and increase participation in their preferred leisure activities. Resting splints may be prescribed for children to wear during the night to reduce swelling and stiffness in joints, allowing them to have less pain and stiffness while participating in play activities. Furthermore, working splints are used to support the joint and relieve pain while working with the hands such as during crafts. A series of casts might be used to gradually extend shortened muscles, allowing for increased participation in leisure activities.
OTs can help children learn how to interact with their classmates and friends by collaboratively brainstorming strategies, role playing, and modeling. OTs also help children see what activities they are good at and which ones give them difficulty. Furthermore, OTs can help children learn to communicate their pain to others. Benefits of OT treatment include: improved social interaction, improved self-confidence, and a positive self-image. OTs can help children build friendships with other children suffering from similar diseases to help them feel less alone or less different from others. Many OTs run summer camps for children with similar diseases so children can get to know others with their disease. Education sessions on JIA and leisure, and activities such as swimming, canoeing and nature trails are common.
For children who find that cool or damp weather makes it hard to play with friends outside, OTs can give ideas for clothing that keep the child warm and dry without limiting movement. An example of this is biking gloves, which allow children to move their fingers while still keeping their hands warm, as opposed to large winter gloves which limit hand function. Warm pajamas and electric blankets can reduce pain and improve sleep.
Children with JIA often require school activity modifications due to disease symptoms. OTs can work with families and schools to improve attendance at school. Therapists help children to succeed by providing ways for full participation at school by working with staff, taking part in activity planning and assessing the need for accommodations and adaptations.
OTs work with children, families and schools to develop strategies for helping children manage pain, stiffness and tiredness, which may sometimes limit their ability to participate in school related activities. A balanced plan will allow children to get enough activity that they do not stiffen up, but also enough rest that they do not tire. For example, a plan might be worked out with a teacher so a child will be allowed to stand and stretch during prolonged sitting, perform modified gym activities or take rest breaks during gym classes. Other common management strategies taught by OTs include waking up early before school and taking a hot bath and then doing exercises to reduce stiffness and pain throughout the day. Using proper body movements when performing activities helps reduce strain on joints and thereby decrease pain and stiffness. OTs can also teach children how to relax their muscles.
OTs may prescribe special equipment for children at school to make them more comfortable. Desks and chairs of a proper height for children are very important. The desk may have the ability to tilt into a comfortable position for writing. Pencils and pens with larger, softer grips can be used to make writing easier and less painful. Special keyboards may be prescribed to keep a child’s arms in a position that will reduce strain on joints when using a computer. OTs can work with teachers to educate them about a child’s condition, limitations and ways they can help make school a positive experience for the child. Recommendations might include two sets of textbooks, one for home one for school, to prevent carrying a heavy load of books. Additional recommendations may involve a reduced amount of writing and typing, sitting on a chair instead of the floor, extra time to move between classes, an elevator key for schools that have elevators but restrict them to students with health problems, providing a student note-taker, and extra time to complete assignments.
As teenagers become adults, OTs can start working with them regarding their future education and employment plans. OTs can assist teenagers in finding ways to tell their employers about their disease in a positive way. OTs can also help teenagers understand their rights as an employee with a disability. Assistance with obtaining funding for post-secondary education might be provided. OTs may help teenagers set up volunteering in the community, to gain experience and self-confidence in their abilities. It is important that teenagers with JIA understand how to take care of themselves and manage their disease when working full-time or attending university. OTs can help teenagers develop strategies that will allow them to function at their greatest ability by taking care of their health.
This section needs to be updated.(December 2015)
As of 1999[update]: With early and aggressive therapy, some children do improve with time and lead normal lives. However, severe cases of JIA which are not treated promptly can lead to poor growth and worsening of joint function. Since about 1980, significant improvements have been made in treatment of JIA and most children can lead a decent quality of life. In order to improve the prognosis of JIA, patients should schedule routine echocardiographic screening to assess heart function. New research shows that identifying what type of JIA a child has can help target treatment and lead to more positive outcomes. Identifying the specific biomarkers related to each type of JIA can help form more personalized treatment plans and decrease remission rates.
Children with JIA are more susceptible to cardiovascular disease, depression, sleep disturbance, anxiety and fatigue than healthy individuals. There is also limited information that suggests that children with JIA are at increased risk for malignancies when being treated with TNF blockers. Prognosis is more positive when gene testing is undergone to identify what subtype of JIA is present in the child. Standardized treatment protocols are in place specific to each subtype of JIA. Treatment is more successful when targeted to the specific subtype of JIA.
JIA occurs in both sexes, but like other rheumatological diseases, is more common in females. Symptoms onset is frequently dependent on the subtype of JIA and is from the preschool years to the early teenaged years.
Juvenile idiopathic arthritis affects between eight and 150 of every 100,000 children, depending on the analysis. Of these children, 50% have pauciarticular JIA, 40% have polyarticular JIA, and 10% have systemic JIA. In a preselected group (children under 16 years with orthodontic treatment need), prevalence rises to one out of 100 (0.88% out of 1024 children).
The terminology used is evolving, and each term has some limitations.
JIA is sometimes referred to as juvenile chronic arthritis (JCA), a term that is not precise as JIA does not encompass all forms of chronic childhood arthritis.
A majority of cases are rheumatoid factor negative, which leads some to consider the "chronic" or "idiopathic" labels more appropriate. However, if a cause was determined, then "idiopathic" may no longer be appropriate (making JIA a diagnosis of exclusion), and if the course was self-limited, then "chronic" may no longer be appropriate.
Adding to the confusion, the term rheumatoid itself lacks a consistent, unambiguous definition.
- Mehta J, Pessler F. "Juvenile Idiopathic Arthritis (JIA): Joint Disorders:". Merck Manual Professional. Retrieved 2008-12-15.
- "Questions and Answers about Juvenile Arthritis (Juvenile Idiopathic Arthritis, Juvenile Rheumatoid Arthritis, and Other Forms of Arthritis Affecting Children)". National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Information Clearinghouse National Institutes of Health. October 2012. Retrieved 19 December 2012.
Prevalence statistics for JA vary, but according to a 2008 report from the National Arthritis Data Workgroup,1 about 294,000 children age 0 to 17 are affected with arthritis or other rheumatic conditions.
- Shiel WC. "Juvenile Rheumatoid Arthritis:". MedicineNet. p. 1. Retrieved 21 December 2012.
Arthritis affects approximately one child in every 1,000 in a given year. Fortunately, most of these cases are mild. However, approximately one child in every 10,000 will have more severe arthritis that doesn't just go away.
- Hoffart C, Sherry DD (February 2010). "Early identification of juvenile idiopathic arthritis: a better understanding helps physicians formulate treatment decisions". Journal of Musculoskeletal Medicine. 27 (2): 51.
- Petty RE (2016). Pediatric Rheumatology. Philadelphia, PA: Elsevier. p. 191. ISBN 978-0-323-24145-8.
- Weiss JE, Ilowite NT (August 2007). "Juvenile idiopathic arthritis". Rheumatic Diseases Clinics of North America. 33 (3): 441–70, vi. doi:10.1016/j.rdc.2007.07.006. PMID 17936173.
- "Juvenile Arthritis Symptoms". Retrieved 2010-04-19.
- "Eye Problems and Juvenile Idiopathic Arthritis". AboutKidsHealth.ca. The Hospital for Sick Children. Retrieved 1 February 2012.
- "Complications of Juvenile Idiopathic Arthritis". AboutKidsHealth.ca. Retrieved 1 February 2012.
- Prahalad S, Glass DN (2002). "Is juvenile rheumatoid arthritis/juvenile idiopathic arthritis different from rheumatoid arthritis?". Arthritis Research. 4 (Suppl 3): 303–310. doi:10.1186/ar594. PMC 3273047.
- Hinks A, Cobb J, Marion MC, Prahalad S, Sudman M, Bowes J, et al. (June 2013). "Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis". Nature Genetics. 45 (6): 664–9. doi:10.1038/ng.2614. PMC 3673707. PMID 23603761.
- "Juvenile Arthritis". Retrieved 2010-04-19.[permanent dead link]
- "Arthritis, Rheumatoid". Retrieved 2010-04-19.
- Phelan JD, Thompson SD (September 2006). "Genomic progress in pediatric arthritis: recent work and future goals". Current Opinion in Rheumatology. 18 (5): 482–9. doi:10.1097/01.bor.0000240359.30303.e4. PMID 16896287.
- Førre O, Smerdel A (2002). "Genetic epidemiology of juvenile idiopathic arthritis". Scandinavian Journal of Rheumatology. 31 (3): 123–8. doi:10.1080/713798345. PMID 12195624.
- "Juvenile Arthritis: Arthritis Is A Children's Disease Too". Retrieved 2010-04-19.
- "Farber Disease". Retrieved 2014-01-21.
- Sherry D, Bhaskar AR, Poduval M. "Juvenile Idiopathic Arthritis Differential Diagnoses". emedicine.medscape.com. Retrieved 11 November 2017.
- Burnham JM, Shults J, Dubner SE, Sembhi H, Zemel BS, Leonard MB (August 2008). "Bone density, structure, and strength in juvenile idiopathic arthritis: importance of disease severity and muscle deficits". Arthritis and Rheumatism. 58 (8): 2518–27. doi:10.1002/art.23683. PMC 2705769. PMID 18668565.
- Chen CY, Tsao CH, Ou LS, Yang MH, Kuo ML, Huang JL (February 2002). "Comparison of soluble adhesion molecules in juvenile idiopathic arthritis between the active and remission stages". Annals of the Rheumatic Diseases. 61 (2): 167–70. doi:10.1136/ard.61.2.167. PMC 1753987. PMID 11796405.
- "www.ped.med.utah.edu". Archived from the original on 2001-04-22. Retrieved 2008-12-15.
- Kasapçopur O, Yologlu N, Ozyazgan Y, Ercan G, Caliskan S, Sever L, Ozdogan H, Arisoy N (October 2004). "Uveitis and anti nuclear antibody positivity in children with juvenile idiopathic arthritis". Indian Pediatrics. 41 (10): 1035–9. PMID 15523130.
- "Disease Center: Juvenile Rheumatoid Arthritis". Arthritis Foundation. Archived from the original on 27 July 2008. Retrieved 27 October 2009.
- Shiel WC. "Juvenile Arthritis". p. 3. medicinenet.com - When?
- "systemic onset juvenile rheumatoid arthritis" at Dorland's Medical Dictionary
- De Benedetti F, Meazza C, Vivarelli M, Rossi F, Pistorio A, Lamb R, Lunt M, Thomson W, Ravelli A, Donn R, Martini A (May 2003). "Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis". Arthritis and Rheumatism. 48 (5): 1398–407. doi:10.1002/art.10882. PMID 12746913.
- Luthi F, Zufferey P, Hofer MF, So AK (2002). ""Adolescent-onset Still's disease": characteristics and outcome in comparison with adult-onset Still's disease". Clinical and Experimental Rheumatology. 20 (3): 427–30. PMID 12102485.
- "What is the outlook (prognosis) for children with arthritis?". Retrieved 2010-04-19.
- Shiel WC. "Juvenile Rheumatoid Arthritis". Retrieved 21 December 2012.
From a doctor's point of view, the most important thing is to bring inflammatory arthritis under control as quickly as possible....This may also require use of some fairly strong medications, but it's important to recognize that they are necessary to reduce symptoms and prevent permanent damage.
- Shiel WC. "Juvenile Rheumatoid Arthritis:". Retrieved 21 December 2012.
...more severe cases may require more aggressive "second-line" medications, such as gold shots, sulfasalazine, or methotrexate.
- "Questions and Answers about Juvenile Arthritis (Juvenile Idiopathic Arthritis, Juvenile Rheumatoid Arthritis, and Other Forms of Arthritis Affecting Children)". NIAMS. Retrieved 21 December 2012.
DMARDs slow the progression of JA, but because they may take weeks or months to relieve symptoms, they often are taken with an NSAID. Although many different types of DMARDs are available, doctors are most likely to use one particular DMARD, methotrexate, for children with JA. Researchers have learned that methotrexate is safe and effective for some children with JA whose symptoms are not relieved by other medications.
- Hashkes PJ, Laxer RM (October 2005). "Medical treatment of juvenile idiopathic arthritis". JAMA. 294 (13): 1671–84. doi:10.1001/jama.294.13.1671. PMID 16204667.
- Lovell DJ, Reiff A, Ilowite NT, Wallace CA, Chon Y, Lin SL, Baumgartner SW, Giannini EH (May 2008). "Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis". Arthritis and Rheumatism. 58 (5): 1496–504. doi:10.1002/art.23427. PMID 18438876.
- Alpigiani MG, Ravera G, Buzzanca C, Devescovi R, Fiore P, Iester A (1996). "[The use of n-3 fatty acids in chronic juvenile arthritis]". La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics (in Italian). 18 (4): 387–90. PMID 9064671.(Abstract in English, article in Italian)
- Vargová V, Veselý R, Sasinka M, Török C (November 1998). "[Will administration of omega-3 unsaturated fatty acids reduce the use of nonsteroidal antirheumatic agents in children with chronic juvenile arthritis?]". Casopis Lekaru Ceskych (in Slovak). 137 (21): 651–3. PMID 9929929.(abstract in English, article in Slovak)
- Foeldvari I, Szer IS, Zemel LS, Lovell DJ, Giannini EH, Robbins JL, West CR, Steidle G, Krishnaswami S, Bloom BJ (January 2009). "A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis". The Journal of Rheumatology. 36 (1): 174–82. doi:10.3899/jrheum.080073. PMID 19012356. Archived from the original on 2016-05-23. Retrieved 2008-12-16.
- "Health News". Retrieved 2010-04-19.
- Nugent J. CCAA Kids With Arthritis: Occupational Therapy [Online] 2010 [cited 2010 April 2]; Available from: URL http://www.ccaa.org.uk/index.php?id=10
- Radomski MV, Trombly Latham CA (2008). Occupational therapy for physical dysfunction (6th ed.). Baltimore: Lippincott Williams & Wilkens.
- De Monte R, Rodger S, Jones F, Broderick S (August 2009). "Living with juvenile idiopathic arthritis: children's experiences of participating in home exercise programmes". British Journal of Occupational Therapy. 72 (8): 357–65. doi:10.1177/030802260907200806.
- Schroder N, Crabtree MJ, Lyall-Watson S (February 2002). "The effectiveness of splinting as perceived by the parents of children with juvenile idiopathic arthritis". British Journal of Occupational Therapy. 65 (2): 75–80. doi:10.1177/030802260206500205.
- Hackett J (July 2003). "Perceptions of Play and Leisure in Junior School Aged Children with Juvenile Idiopathic Arthritis: What are the Implications for Occupational Therapy?". British Journal of Occupational Therapy. 66 (7): 303–310. doi:10.1177/030802260306600704.
- Miller-Hoover S (2005). "Juvenile idiopathic arthritis: why do I have to hurt so much?". Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society. 28 (6): 385–91. PMID 16304496.
- "Occupational Therapy Facts [Online] 2003-2010". Canadian Association of Occupational Therapists. Retrieved 2 April 2010.
- Atchinson BJ, Dirette DK, eds. (2007). Conditions in occupational therapy. Effect on occupational performance (3rd ed.). Philadelphia: Lippincott, Williams & Wilkins.
- Shaw KL, Hackett JL, Southwood TR, McDonagh JE (November 2006). "The prevocational and early employment needs of adolescents with juvenile idiopathic arthritis: the occupational therapy perspective". British Journal of Occupational Therapy. 69 (11): 497–503. doi:10.1177/030802260606901103.
- Barut K, Adrovic A, Şahin S, Kasapçopur Ö (April 2017). "Juvenile Idiopathic Arthritis". Balkan Medical Journal. 34 (2): 90–101. doi:10.4274/balkanmedj.2017.0111. PMID 28418334.
- Giancane G, Consolaro A, Lanni S, Davì S, Schiappapietra B, Ravelli A (December 2016). "Juvenile Idiopathic Arthritis: Diagnosis and Treatment". Rheumatology and Therapy. 3 (2): 187–207. doi:10.1007/s40744-016-0040-4. PMC 5127964. PMID 27747582.
- Oberle EJ, Harris JG, Verbsky JW (24 October 2014). "Polyarticular juvenile idiopathic arthritis - epidemiology and management approaches". Clinical Epidemiology. 6: 379–93. doi:10.2147/CLEP.S53168. PMC 4216020. PMID 25368531.
- Weber J, Weber D, Tzaribachev N (2011). "High frequency of temporomandibular joint-isolated juvenile idiopathic arthritis in children with orthodontic treatment need". OP46, EOS. Istanbul, Türkei. Archived from the original on 2011-06-28.
- Ringold S, Burke A, Glass RM (October 2005). "JAMA patient page. Juvenile idiopathic arthritis". JAMA. 294 (13): 1722. doi:10.1001/jama.294.13.1722. PMID 16204672.
- "juvenile rheumatoid arthritis" at Dorland's Medical Dictionary
- Dana D, Erstad S. "Juvenile Idiopathic Arthritis". Archived from the original on 7 January 2008. Retrieved 11 March 2007.
- "Case Based Pediatrics Chapter". Retrieved 2008-12-15.
- Juvenile Rheumatoid Arthritis at the US National Library of Medicine Medical Subject Headings (MeSH)
- JIA - NIH Medline Plus.